Schizophrenia

Schizophrenia serves as a recurring reference point in the book’s account of how psychiatry tried to understand psychedelic drugs. The index connects it to the emergence of neurochemistry, the psychotomimetic model, concerns about LSD triggering psychotic breaks, a rotating-face-mask test, and research at Spring Grove. Taken together, these references place the condition at the intersection of psychiatric theory, experimental methods, and debates about the risks of psychedelics, while the available account does not turn schizophrenia into a single patient’s story or offer a detailed clinical profile.

A Reference Point in Psychiatric History

The book associates schizophrenia with the emergence of neurochemistry, directing readers to a discussion on pages 146–47. That connection locates the condition within a changing account of mental illness: psychiatric explanations were increasingly being shaped by attention to the brain’s chemistry. The index supplies the historical association, but not a detailed account of the research or claims made on those pages; it therefore signals a change in disciplinary emphasis rather than establishing a particular chemical explanation for schizophrenia.

This historical placement matters to the psychedelic story because a central early framework interpreted the drugs by comparing their effects with familiar forms of mental illness. In the psychotomimetic model, psychedelic effects were understood as resembling psychoses. The book describes this model as compatible with established psychiatric thinking, in contrast to later approaches that emphasized psychological treatment or spiritual experience. Schizophrenia’s indexed connection to the model marks it as part of this psychiatric frame of reference, not as interchangeable with a drug-induced state.

The Psychotomimetic Model and LSD

The index links schizophrenia directly to the psychotomimetic model on pages 145–46 and 162. In the book’s broader account, the model offered a way to make sense of psychedelics by treating their effects as a temporary imitation of recognizable psychiatric disturbance. That interpretation gave clinicians a familiar vocabulary for investigating unusual experiences. It also shaped the questions researchers asked: if a drug could produce effects resembling psychosis, it might serve as a means of studying mental illness.

The book also indexes schizophrenia in connection with LSD as a trigger of psychotic breaks, referring readers to pages 209–10. The distinction between a resemblance used to construct a research model and a feared or reported psychiatric consequence is important. The first concerns how researchers classified the drug’s effects; the second concerns the possibility that LSD could precipitate a serious disturbance. The index establishes that the book addresses both strands, but the evidence available here does not specify the cases, frequency, or conditions involved. It does not support treating every psychedelic experience as psychosis, or claiming that the cited references establish a general causal rule.

Tests and Research Settings

Two further index entries connect schizophrenia to experimental research. One points to a rotating-face-mask test on page 262, placing the condition in relation to a specific perceptual test discussed elsewhere in the book. The index alone does not explain how the test was performed, what participants experienced, or what conclusions researchers drew. Its significance here is narrower: schizophrenia is included among the book’s topics where experimental methods and the study of perception meet.

The other entry associates schizophrenia with research at Spring Grove, with a reference to page 218. This situates the condition within the book’s account of a research center involved in psychedelic studies. The entry does not identify a particular schizophrenia treatment, trial outcome, or change in clinical practice. Accordingly, Spring Grove is evidence of a research connection in the book’s historical map, not grounds for attributing a specific result to the institution.

Meaning and Limits of the Connection

Across these references, schizophrenia helps show how the interpretation of psychedelics shifted among psychiatric resemblance, experimental investigation, and concern about possible harm. The psychotomimetic model made the drugs legible to psychiatry by relating their effects to familiar psychoses; the indexed discussion of LSD-triggered breaks records the corresponding risk question. References to neurochemistry, perceptual testing, and Spring Grove widen the frame from theory to research history.

The book’s organization also imposes a useful limit on what can be concluded. Its index records several distinct connections, but the available passages do not provide enough detail to reconstruct the specific studies or clinical evidence behind them. Schizophrenia is therefore best understood here as a recurring concept in the history of psychedelic science: a diagnostic and theoretical reference point through which researchers debated what psychedelic states resemble, how they might be studied, and where resemblance ends and danger begins.